SARS-CoV-2 is primarily an airborne infection of the upper respiratory tract, which on
reaching the lungs causes the severe acute respiratory disease, COVID-19. Its first contact …

There is an urgent need for a safe and protective vaccine to control the global spread of
SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective …

Background Capsid virus-like particles (cVLP) have proven safe and immunogenic and can
be a versatile platform to counter pandemics. We aimed to clinically test a modular cVLP …

Background To mitigate the effects of COVID-19, a vaccine is urgently needed. BBV152 is a
whole-virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …

Background Although the BNT162b2 COVID-19 vaccine is known to induce IgG neutralizing
antibodies in serum protecting against COVID-19, it has not been studied in detail whether it …

On Aug 17, 2020, screening began for participants to enrol in the midstage study of an
experimental COVID-19 vaccine by Novavax, a US drug developer of next-generation …

Importance Control of the global COVID-19 pandemic will require the development and
deployment of safe and effective vaccines. Objective To evaluate the immunogenicity of the …

SARS-CoV-2 antibody assays are crucial in managing the COVID-19 pandemic. Approved
mRNA COVID-19 vaccines are well known to induce a serum antibody responses against …

Abstract Background The inactivated Sinopharm/BBIBP COVID‐19 vaccine has been widely
used in the world and has joined the COVAX vaccine supply program for developing …

Background The currently used SARS-CoV-2 mRNA vaccines have proven to induce a
strong and protective immune response. However, functional relevance of vaccine …